Subgroup analyses stratified by primary tumor origin showed a trend toward shorter overall survival in patients with higher Ki-67 expression across spinal metastases from prostate, lung and breast cancer; however, these differences were not statistically significant within individual tumor entities ( Figure 2 C).
← all excerpts
The Prognostic Impact of the Ki-67 Proliferation Index in Patients with Surgically Treated Spinal Metastases.
1
—
—